SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

SEC Comment Letter 0000000000-25-002651 to Adicet Bio, Inc. (ACET) (CIK 0001720580) (ACET)

Adicet Bio, Inc. (ACET) (CIK 0001720580)
Date: March 11, 2025 · CIK: 0001720580 · Accession: 0000000000-25-002651

Offering / Registration Process

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-285609

Date
March 11, 2025
Author
Division of
Form
UPLOAD
Company
Adicet Bio, Inc. (ACET) (CIK 0001720580)

Letter

Re: Adicet Bio, Inc. Registration Statement on Form S-3 Filed March 6, 2025 File No. 333-285609 Dear Chen Schor:

March 11, 2025

Chen Schor Chief Executive Officer Adicet Bio, Inc. 131 Dartmouth Street, 3rd Floor Boston, MA 02116

This is to advise you that we have not reviewed and will not review your registration statement.

Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.

Please contact Tyler Howes at 202-551-3370 with any questions.

Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Gabriela Morales-Rivera, Esq.

Show Raw Text
<DOCUMENT>
<TYPE>TEXT-EXTRACT
<SEQUENCE>2
<FILENAME>filename2.txt
<TEXT>
 March 11, 2025

Chen Schor
Chief Executive Officer
Adicet Bio, Inc.
131 Dartmouth Street, 3rd Floor
Boston, MA 02116

 Re: Adicet Bio, Inc.
 Registration Statement on Form S-3
 Filed March 6, 2025
 File No. 333-285609
Dear Chen Schor:

 This is to advise you that we have not reviewed and will not review your
registration
statement.

 Please refer to Rules 460 and 461 regarding requests for acceleration.
We remind you
that the company and its management are responsible for the accuracy and
adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action
by the staff.

 Please contact Tyler Howes at 202-551-3370 with any questions.

 Sincerely,

 Division of
Corporation Finance
 Office of Life
Sciences
cc: Gabriela Morales-Rivera, Esq.
</TEXT>
</DOCUMENT>